Our previous studies have shown that when Th17 differentiation is inhibited (Figure 6A), the expression of the anti-inflammatory cytokine IL-10 is upregulated (Figure 6B), which is an essential regulatory mechanism for T-cell-mediated mucosal inflammation in IBD (21). Here, IL10 is linked to irritable bowel syndrome.